Pharmaceuticals, Biotechnology & Life Sciences

Genomma Lab Internacional rises 3.9%—track its 52‑week highs, market cap and 200‑day SMA to spot buying opportunities in Mexico’s OTC drug market.

Engene Therapeutics: US biotech shares trade at $1.58, 52‑week low $1.4, market cap $104.6 M, down 18.8% month‑end. Get real‑time price, volume, and trend insights.

China Sanjiu Med shares hit a flat 0% close, trading at CNY 25.05 amid a 5.94% rise this month; discover key price levels, market cap and industry context.

Panion & Bf Biotech shares fell 1.52% to TWD 51.7, trading below its 200‑day SMA and 52‑week low, while investors watch market shifts in Taiwan’s biotech sector.

Gt Biopharma stock falls 1.09% to $5.07, trading down 20% since last month; 52‑week high $11.98 and low $0.22, amid biotech market shifts.

Explore Kyntra Bio’s latest market dip, its $18.6 m cap, and how it ranks against peers—ideal for traders seeking biotech insights.

Humanwell Healthcare: flat 0% trade, current price ¥19.7, 200‑day SMA at ¥18, 52‑week high ¥21.68. Get the latest market cap and trading insights now.

Circle (CIRC) stock dips 1.73% to $0.24, trading $245k today. 200‑day SMA $1.66, 52‑wk high $4.56. Compare with Sypris, Dogwood, XOS, AXIL, VERU.

Opus Genetics stocks fall 28.8% from month‑end, trading at $3.32 with a $288M market cap; discover recent price trends and compare to peers.

Unicocell Biomed dips 8.53% in 2026—trading at TWD 68.6 with a TWD 4.4 bn market cap; see 52‑week highs/lows and recent movers for insight.